106 related articles for article (PubMed ID: 29448178)
1. Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
McGregor N; Thompson N; O'Connell KS; Emsley R; van der Merwe L; Warnich L
Psychiatry Res; 2018 Apr; 262():141-148. PubMed ID: 29448178
[TBL] [Abstract][Full Text] [Related]
2. Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms.
Ovenden ES; Drögemöller BI; van der Merwe L; Chiliza B; Asmal L; Emsley RA; Warnich L
Pharmacogenomics; 2017 Jan; 18(2):105-120. PubMed ID: 27992301
[TBL] [Abstract][Full Text] [Related]
3. Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Phahladira L; Kilian S
Psychol Med; 2017 Sep; 47(12):2187-2196. PubMed ID: 28347393
[TBL] [Abstract][Full Text] [Related]
4. Rate and predictors of non-response to first-line antipsychotic treatment in first-episode schizophrenia.
Chiliza B; Asmal L; Kilian S; Phahladira L; Emsley R
Hum Psychopharmacol; 2015 May; 30(3):173-82. PubMed ID: 25758549
[TBL] [Abstract][Full Text] [Related]
5. Prolactin, flupenthixol decanoate and first episode schizophrenia - clinical and laboratory correlates.
Retief M; Chiliza B; Phahladira L; Emsley R; Asmal L
Metab Brain Dis; 2019 Dec; 34(6):1679-1687. PubMed ID: 31422510
[TBL] [Abstract][Full Text] [Related]
6. The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.
Drögemöller BI; Emsley R; Chiliza B; van der Merwe L; Wright GE; Daya M; Hoal E; Malhotra AK; Lencz T; Robinson DG; Zhang JP; Asmal L; Niehaus DJ; Warnich L
Pharmacogenet Genomics; 2016 May; 26(5):235-42. PubMed ID: 26928376
[TBL] [Abstract][Full Text] [Related]
7. Combining depot antipsychotic with an assertive monitoring programme for treating first-episode schizophrenia in a resource-constrained setting.
Chiliza B; Ojagbemi A; Esan O; Asmal L; Oosthuizen P; Kidd M; Gureje O; Emsley R
Early Interv Psychiatry; 2016 Feb; 10(1):54-62. PubMed ID: 24690088
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature.
Sahu G; Malavade K; Jacob T
Psychiatr Q; 2016 Sep; 87(3):559-69. PubMed ID: 26603624
[TBL] [Abstract][Full Text] [Related]
9. Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.
Emsley R; Asmal L; Chiliza B; du Plessis S; Carr J; Kidd M; Malhotra AK; Vink M; Kahn RS
Psychiatry Res; 2015 Aug; 233(2):186-93. PubMed ID: 26184461
[TBL] [Abstract][Full Text] [Related]
10. Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders.
Hoffmann C; Van Rheenen TE; Mancuso SG; Zalesky A; Bruggemann J; Lenroot RK; Sundram S; Weickert CS; Weickert TW; Pantelis C; Cropley V; Bousman CA
Psychiatry Res Neuroimaging; 2018 Nov; 281():61-68. PubMed ID: 30253269
[TBL] [Abstract][Full Text] [Related]
11. GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma.
Koga A; Bani-Fatemi A; Hettige N; Borlido C; Zai C; Strauss J; Gerretsen P; Graff A; Remington G; De Luca V
Pharmacogenomics; 2017 May; 18(7):663-671. PubMed ID: 28453389
[TBL] [Abstract][Full Text] [Related]
12. A report on the use of flupenthixol in the maintenance treatment of psychotic patients at Ibadan, Nigeria.
Jegede RO; Ibazebo H
Afr J Psychiatry; 1981; 7(1-2):21-4. PubMed ID: 6122369
[No Abstract] [Full Text] [Related]
13. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis.
Vázquez-Bourgon J; Arranz MJ; Mata I; Pelayo-Terán JM; Pérez-Iglesias R; Medina-González L; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
Psychiatry Res; 2010 Feb; 175(3):189-94. PubMed ID: 20031235
[TBL] [Abstract][Full Text] [Related]
14. A History of Childhood Trauma and Response to Treatment With Antipsychotics in First-Episode Schizophrenia Patients: Preliminary Results.
Misiak B; Frydecka D
J Nerv Ment Dis; 2016 Oct; 204(10):787-792. PubMed ID: 27441460
[TBL] [Abstract][Full Text] [Related]
15. Fluphenazine and flupenthixol decanoate in psychiatric outpatients practice.
Coufal J; Novotný M
Act Nerv Super (Praha); 1981 Dec; 23(4):269-71. PubMed ID: 6121439
[No Abstract] [Full Text] [Related]
16. Genetic variations of PIP4K2A confer vulnerability to poor antipsychotic response in severely ill schizophrenia patients.
Kaur H; Jajodia A; Grover S; Baghel R; Gupta M; Jain S; Kukreti R
PLoS One; 2014; 9(7):e102556. PubMed ID: 25025909
[TBL] [Abstract][Full Text] [Related]
17. Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian Samples.
Calabrò M; Porcelli S; Crisafulli C; Wang SM; Lee SJ; Han C; Patkar AA; Masand PS; Albani D; Raimondi I; Forloni G; Bin S; Mattiaccio A; Mantovani V; Jun TY; Pae CU; Serretti A
Adv Ther; 2017 Jun; 34(6):1482-1497. PubMed ID: 28508933
[TBL] [Abstract][Full Text] [Related]
18. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.
Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J
Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613
[TBL] [Abstract][Full Text] [Related]
19. Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.
Ruderfer DM; Charney AW; Readhead B; Kidd BA; Kähler AK; Kenny PJ; Keiser MJ; Moran JL; Hultman CM; Scott SA; Sullivan PF; Purcell SM; Dudley JT; Sklar P
Lancet Psychiatry; 2016 Apr; 3(4):350-7. PubMed ID: 26915512
[TBL] [Abstract][Full Text] [Related]
20. The association between childhood trauma and treatment outcomes in schizophrenia spectrum disorders.
Kilian S; Asmal L; Phahladira L; Plessis SD; Luckhoff H; Scheffler F; Buckle C; Emsley R
Psychiatry Res; 2020 Jul; 289():113004. PubMed ID: 32387789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
